Heart Failure stratification. Studies reasonably anticipated to show that Galectin-3 aids in the risk stratification of Heart Failure patients and provides additional clinical information versus other commonly used cardiac markers such as BNP, and NT-BNP.
Appears in 4 contracts
Samples: Galectin 3 License and Distribution Agreement (BG Medicine, Inc.), Galectin 3 License and Distribution Agreement (BG Medicine, Inc.), Galectin 3 License and Distribution Agreement (BG Medicine, Inc.)